Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico

This publication has 27 references indexed in Scilit:

• Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6–17 months of age: Dosing studies in different age groups
  Vaccine, 2006
• Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and Prevention
  Clinical Microbiology Reviews, 2005
• Second‐Year Follow‐up Evaluation of Live, Attenuated Human Rotavirus Vaccine 89‐12 in Healthy Infants
  The Journal of Infectious Diseases, 2002
• Dose-Dependent Circulating Immunoglobulin A Antibody-Secreting Cell and Serum Antibody Responses in Swedish Volunteers to an Oral Inactivated Enterotoxigenic Escherichia coli Vaccine
  Clinical and Diagnostic Laboratory Immunology, 2001
• Intestinal antibody response after oral immunization with a prototype cholera B subunit — colonization factor antigen enterotoxigenic Escherichia coli vaccine
  Vaccine, 1993
• Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up
  The Lancet, 1990
• Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea
  European Journal of Clinical Microbiology & Infectious Diseases, 1989
• Cross-Protection by B Subunit-Whole Cell Cholera Vaccine Against Diarrhea Associated with Heat-Labile Toxin-Producing Enterotoxigenic Escherichia coli: Results of a Large-Scale Field Trial
  The Journal of Infectious Diseases, 1988
• Antimicrobial Agents in the Prevention of Travelers' Diarrhea
  Clinical Infectious Diseases, 1986
• Prophylactic Doxycycline for Travelers' Diarrhea
  New England Journal of Medicine, 1978